More recent cytological interest has led to Some clinicians still regard diagnostic cytology positive attempts to qualify and separate these with scepticism, despite convincing statistical and lesions morphologically, and several papers from clinical evidence supporting its diagnostic the United Kingdom, Canada and Scandinavia usefulness. More recent accumulation of evidence (Hutton et al. 1978 , Morse et al. 1982 supports the sensitivity and wider application of al. 1982 , Ferenczy & Gelfand 1984 have shown cytological techniques in fine needle aspiration of that cytologists can attain an acceptable level of solid and cystic masses , sensitivity and specificity in the diagnosis of such Nadji et al. 1979) .
lesions, certainly to support endometrial cytology
It is therefore especially disappointing that as an efficient screening procedure in various endometrial aspiration cytology is continually groups of patients attending gynaecological being overlooked by many gynaecologists, parti-clinics.
cularly since the role of cytology has always been Endometrial cytology is not offered as an recognized in its application to cervical intraalternative to detailed histological assessment; epithelial neoplasia, and has become increasingly grade and extent of lesion are of paramount important in the selection and follow up of importance in treatment. However, the patients treated for such lesions by ablative assumption that a histological diagnosis based on techniques.
the average curettage sample should be regarded The last seven years have seen a resurgence of as any more definitive than a cytological opinion interest in direct endometrial sampling, and is unreasonable. The curettage is often likely to numerous instruments are currently available, have been done by the least experienced member
The limitations of the standard cervical smear in of the clinical team. The specialist gynaecological the recognition of endometrial carcinoma have pathologist has a particular interest and expertise. long been known, and as early as 1943 Cary used The general pathologist may vary considerably in a metal cannula attached to a syringe for direct his or her ability, interest and subjectivity sampling of endometrium for cytological assesstowards gynaecological pathology.
ment. Since then countless instruments have been
It has been suggested that outpatient curettage tried and abandoned (Morse 1981) . Modern should be regarded as more accurate than materials and techniques have overcome many of outpatient endometrial aspiration (Studd et al. these earlier problems, and some authors have 1979). It is certainly more painful for patients begun to question the accuracy of conventional than most cytological methods and the histocurettage (Grimes 1982) . The current trend away logical sample can be unrepresentative and from unnecessary general anaesthesia and inadequate. There is convincing evidence that hospital admission, for financial and medical endometrial cytology can offer the practising reasons, has led to a critical appraisal of areas clinician an accurate and reliable method of where outpatient assessment and diagnosis can be preliminary outpatient investigation, with the efficiently applied. minimum upset and inconvenience to the patient, Arguments that conventional curettage obtains so that women who require a more detailed a more representative and satisfactory sample can investigation can be confidently selected from be easily refuted. Recent papers have shown that those who need only reassurance and discrepancies occur with histological sampling as conservative management. Surely this is a better well as with cytological sampling and that an alternative than to continue to investigate all such adequate sample for cytological assessment can patients by conventional curettage, particularly be obtained in up to 25% of cases where since in a high percentage no significant abcurettage failed to obtain any specimen at all normality will be found and curettage will (Segadal & Iversen 1980 , Polson et al. 1984 . contribute nothing at all to their management?
In the past it could be argued that cytologists As in so many other areas of medicine, were looking only for the gross changes Of endometrial cytology does require the active adenocarcinoma, and that the other significant cooperation of clinician and cytologist. The conditions of atypical and cystic hyperplasia were clinician needs to be experienced and interested; a 1Arising from presentation to Section of Obstetrics & recent paper highlighted the limitations of ju.nior Gynaecology, 22 also requires experience and a special interest, not exceptional qualities. All these requirements are readily available, with a little effort and positive motivation.
Medicine is a dynamic subject; the patients in our care surely deserve the time it takes to address critically the alternative approaches to patient management and review traditional procedures. The time has come for clinicians and cytologists alike to debate the advantages and disadvantages of a more flexible and sympathetic approach to the management of gynaecological problems, with an honest appraisal of the true worth and application of current alternative methods of diagnosis. 
Antiviral treatment of chronic hepatitis B virus infection
There are probably more than 175 million carriers of the hepatitis B virus (HBV) in the world today. These individuals are at risk of developing chronic hepatitis, cirrhosis, and primary liver cell carcinoma. An effective treatment of HBV infection and its associated liver disease is therefore urgently needed. Although antiviral therapy for chronic HBV infection is not yet available for general clinical use, several promising compounds have been identified which possess specific activity against HBV in man. There are two phases of chronic HBV infection. In the first, there is active viral replication with high-titre hepatitis B surface antigen (HBsAg). Hepatitis B e antigen (HBeAg), HBV-DNA, and DNA polymerase are present in the serum, which, along with other body fluids, is infectious. Serum transaminases tend to be elevated, and hepatic histology reveals an active inflammatory lesion. After a variable length of time, usually several years, the patient enters the second phase in which viral replication ceases. The patient has now lost HBeAg and has developed hepatitis B e antibody (anti-HBe). HBV-DNA and DNA polymerase are no longer detectable in the serum but HBsAg continues to be secreted by clones of hepatocytes containing integrated hepatitis B viral DNA (Fowler et al. 1984) . Serum transaminase tends to normalize, and the level of inflammatory necrosis of hepatocytes subsides.
The aim of therapy of chronic HBV infection is to eradicate the virus in both its replicating and non-replicating forms, thereby preventing the development of progressive liver disease and liver cell cancer. The approach to therapy will therefore be dependent on the phase of the infection (HBeAgor anti-HBe-positive). Since HBeAg-positive patients have an active liver disease and are infectious, they stand to derive the greatest benefit from antiviral therapy. In this group, the goal of therapy is a permanent inhibition of HBV replication. This will be reflected serologically by loss of serum HBV-DNA and DNA polymerase, seroconversion from HBeAg to anti-HBe, and decrease in HBsAg titre. These changes are associated with an initial rise and subsequent normalization of serum transaminases, reduction of inflammatory activity in the liver, and decreased infectivity of the patient. If treatment is instituted before stable clones of hepatocytes with integrated hepatitis B viral DNA are established, the patient may also lose HBsAg and HBV will thus be completely eradicated.
Interferon, adenine arabinoside (ARA-A) and its monophosphate (ARA-AMP), and acycloguanosine (acyclovir) are the most promising drugs for treatment of active HBV replication. Interferons are polypeptides which are produced in response to virus infection and 0141-0768/84/120998-04/$O 1.00/0 g 1984 The Royal Society of Medicine
